US Patent 10183012 | Patents | Expiry | Expiration | Dates

IRONWOOD PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

LESINURAD

Supporting Information : Click here to upload a PDF

US Patent Number

10183012

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-11-26

Patent Use Code

U-2311

Delist Requested

Application Number

207988

Patent Use Description

Product Number

1

IRONWOOD PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

ALLOPURINOL; LESINURAD

Supporting Information : Click here to upload a PDF

US Patent Number

10183012

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-11-26

Patent Use Code

U-2104

Delist Requested

Application Number

209203

Patent Use Description

Product Number

1

IRONWOOD PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

ALLOPURINOL; LESINURAD

Supporting Information : Click here to upload a PDF

US Patent Number

10183012

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-11-26

Patent Use Code

U-2104

Delist Requested

Application Number

209203

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10183012

U.S. Patents

IRONWOOD PHARMS INC

LESINURAD

10183012

2028-11-26

U-2311

207988

1

IRONWOOD PHARMS INC

ALLOPURINOL; LESINURAD

10183012

2028-11-26

U-2104

209203

1

IRONWOOD PHARMS INC

ALLOPURINOL; LESINURAD

10183012

2028-11-26

U-2104

209203

2